Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.

@article{Mattsson2015IndependentIF,
  title={Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.},
  author={Niklas Mattsson and Philip S Insel and Michael C Donohue and Susan M. Landau and William J. Jagust and Leslie M. Shaw and John Q. Trojanowski and Henrik Zetterberg and K Blennow and Michael W Weiner},
  journal={Brain : a journal of neurology},
  year={2015},
  volume={138 Pt 3},
  pages={772-83}
}
Reduced cerebrospinal fluid amyloid-β42 and increased retention of florbetapir positron emission tomography are biomarkers reflecting cortical amyloid load in Alzheimer's disease. However, these measurements do not always agree and may represent partly different aspects of the underlying Alzheimer's disease pathology. The goal of this study was therefore to test if cerebrospinal fluid and positron emission tomography amyloid-β biomarkers are independently related to other Alzheimer's disease… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 11 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

Neurodegenerative Diseases

Springer International Publishing • 2018

References

Publications referenced by this paper.
Showing 1-10 of 57 references

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2012
View 2 Excerpts
Highly Influenced

Automatically parcellating the human cerebral cortex.

Cerebral cortex • 2004
View 1 Excerpt
Highly Influenced

Similar Papers

Loading similar papers…